rs6695033

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003748.4(ALDH4A1):​c.1417A>G​(p.Thr473Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0282 in 1,614,048 control chromosomes in the GnomAD database, including 1,503 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T473N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.062 ( 588 hom., cov: 33)
Exomes 𝑓: 0.025 ( 915 hom. )

Consequence

ALDH4A1
NM_003748.4 missense

Scores

1
4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.54

Publications

16 publications found
Variant links:
Genes affected
ALDH4A1 (HGNC:406): (aldehyde dehydrogenase 4 family member A1) This protein belongs to the aldehyde dehydrogenase family of proteins. This enzyme is a mitochondrial matrix NAD-dependent dehydrogenase which catalyzes the second step of the proline degradation pathway, converting pyrroline-5-carboxylate to glutamate. Deficiency of this enzyme is associated with type II hyperprolinemia, an autosomal recessive disorder characterized by accumulation of delta-1-pyrroline-5-carboxylate (P5C) and proline. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2009]
ALDH4A1 Gene-Disease associations (from GenCC):
  • hyperprolinemia type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003748.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016415417).
BP6
Variant 1-18875425-T-C is Benign according to our data. Variant chr1-18875425-T-C is described in ClinVar as Benign. ClinVar VariationId is 294366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003748.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDH4A1
NM_003748.4
MANE Select
c.1417A>Gp.Thr473Ala
missense
Exon 13 of 15NP_003739.2
ALDH4A1
NM_170726.3
c.1417A>Gp.Thr473Ala
missense
Exon 13 of 16NP_733844.1P30038-1
ALDH4A1
NM_001319218.2
c.1264A>Gp.Thr422Ala
missense
Exon 12 of 14NP_001306147.1P30038-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDH4A1
ENST00000375341.8
TSL:1 MANE Select
c.1417A>Gp.Thr473Ala
missense
Exon 13 of 15ENSP00000364490.3P30038-1
ALDH4A1
ENST00000290597.9
TSL:1
c.1417A>Gp.Thr473Ala
missense
Exon 13 of 16ENSP00000290597.5P30038-1
ALDH4A1
ENST00000538839.5
TSL:1
c.1264A>Gp.Thr422Ala
missense
Exon 12 of 14ENSP00000446071.1P30038-3

Frequencies

GnomAD3 genomes
AF:
0.0617
AC:
9375
AN:
152066
Hom.:
586
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0372
Gnomad ASJ
AF:
0.0401
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0186
Gnomad FIN
AF:
0.0235
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0224
Gnomad OTH
AF:
0.0527
GnomAD2 exomes
AF:
0.0310
AC:
7787
AN:
251476
AF XY:
0.0287
show subpopulations
Gnomad AFR exome
AF:
0.166
Gnomad AMR exome
AF:
0.0227
Gnomad ASJ exome
AF:
0.0296
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0270
Gnomad NFE exome
AF:
0.0237
Gnomad OTH exome
AF:
0.0362
GnomAD4 exome
AF:
0.0247
AC:
36180
AN:
1461864
Hom.:
915
Cov.:
31
AF XY:
0.0243
AC XY:
17647
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.166
AC:
5563
AN:
33476
American (AMR)
AF:
0.0239
AC:
1067
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0318
AC:
831
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0172
AC:
1485
AN:
86258
European-Finnish (FIN)
AF:
0.0268
AC:
1433
AN:
53414
Middle Eastern (MID)
AF:
0.0668
AC:
385
AN:
5766
European-Non Finnish (NFE)
AF:
0.0211
AC:
23420
AN:
1111996
Other (OTH)
AF:
0.0330
AC:
1995
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2113
4227
6340
8454
10567
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
954
1908
2862
3816
4770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0617
AC:
9392
AN:
152184
Hom.:
588
Cov.:
33
AF XY:
0.0595
AC XY:
4428
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.161
AC:
6693
AN:
41502
American (AMR)
AF:
0.0371
AC:
567
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0401
AC:
139
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.0187
AC:
90
AN:
4822
European-Finnish (FIN)
AF:
0.0235
AC:
249
AN:
10618
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0224
AC:
1524
AN:
67988
Other (OTH)
AF:
0.0521
AC:
110
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
433
866
1300
1733
2166
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0342
Hom.:
927
Bravo
AF:
0.0676
Asia WGS
AF:
0.0210
AC:
73
AN:
3478
EpiCase
AF:
0.0278
EpiControl
AF:
0.0272

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hyperprolinemia type 2 (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.22
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.40
T
Eigen
Benign
0.19
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Benign
0.60
D
LIST_S2
Pathogenic
0.98
D
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
4.5
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.15
Sift
Benign
0.11
T
Sift4G
Benign
0.068
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.30
gMVP
0.72
Mutation Taster
=29/71
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6695033;
hg19: chr1-19201919;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.